emirates7 - Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake. This strategic acquisition expands Mubadala's presence in the healthcare logistics and pharmaceutical distribution sectors, in line with the UAE's goal of building a strong life sciences infrastructure.
Founded in 2015, GMSC offers end-to-end supply chain services for medical products, covering demand planning, procurement, logistics, inventory management, warehousing, and maintenance. The company serves over 200 medical facilities across the UAE, sourcing products from nearly 400 suppliers to maintain a reliable supply chain for medical needs.
IDS, established in 1987, is a leading distributor of pharmaceutical and consumer healthcare products in the UAE. With a portfolio of over 1,000 products from more than 40 suppliers, IDS supplies hospitals, pharmacies, and supermarkets throughout the UAE. Its product range includes categories such as anti-infectives, asthma, diabetes, and oncology.
Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala’s UAE Investments Platform, stated, "The growing pharmaceutical market is driving the need for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are creating a vertically integrated life sciences sector in the UAE, encompassing everything from logistics and distribution to specialized manufacturing."
Low Ping, Group CEO of Yas Holding, remarked, "This acquisition continues Mubadala's strategic growth, complementing the recent acquisition by its specialty pharmaceutical business, KELIX Bio, which acquired four pharma assets from GlobalOne Healthcare Holding. These efforts highlight Mubadala's commitment to strengthening the UAE’s healthcare and pharmaceutical sectors as part of the broader national objectives for drug security and economic diversification."
GlobalOne Healthcare Holding LLC is the healthcare division of Yas Holding LLC, focused on enhancing healthcare outcomes by investing in innovative solutions across various healthcare sectors.
Founded in 2015, GMSC offers end-to-end supply chain services for medical products, covering demand planning, procurement, logistics, inventory management, warehousing, and maintenance. The company serves over 200 medical facilities across the UAE, sourcing products from nearly 400 suppliers to maintain a reliable supply chain for medical needs.
IDS, established in 1987, is a leading distributor of pharmaceutical and consumer healthcare products in the UAE. With a portfolio of over 1,000 products from more than 40 suppliers, IDS supplies hospitals, pharmacies, and supermarkets throughout the UAE. Its product range includes categories such as anti-infectives, asthma, diabetes, and oncology.
Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala’s UAE Investments Platform, stated, "The growing pharmaceutical market is driving the need for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are creating a vertically integrated life sciences sector in the UAE, encompassing everything from logistics and distribution to specialized manufacturing."
Low Ping, Group CEO of Yas Holding, remarked, "This acquisition continues Mubadala's strategic growth, complementing the recent acquisition by its specialty pharmaceutical business, KELIX Bio, which acquired four pharma assets from GlobalOne Healthcare Holding. These efforts highlight Mubadala's commitment to strengthening the UAE’s healthcare and pharmaceutical sectors as part of the broader national objectives for drug security and economic diversification."
GlobalOne Healthcare Holding LLC is the healthcare division of Yas Holding LLC, focused on enhancing healthcare outcomes by investing in innovative solutions across various healthcare sectors.